标题
Update on psoriasis immunopathogenesis and targeted immunotherapy
作者
关键词
Psoriasis, Etanercept, Ustekinumab, Tofacitinib, Ruxolitinib
出版物
Seminars in Immunopathology
Volume 38, Issue 1, Pages 11-27
出版商
Springer Nature
发表日期
2015-11-16
DOI
10.1007/s00281-015-0539-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New Drugs and Treatment Targets in Psoriasis
- (2015) K Kofoed et al. ACTA DERMATO-VENEREOLOGICA
- Dermal γδ T cells – What have we learned?
- (2015) Rebecca L. O’Brien et al. CELLULAR IMMUNOLOGY
- Genetics of Psoriasis
- (2015) Satveer K. Mahil et al. DERMATOLOGIC CLINICS
- An Update on Topical Therapies for Mild-Moderate Psoriasis
- (2015) Peter C.M. van de Kerkhof DERMATOLOGIC CLINICS
- Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis
- (2015) Kristian Reich et al. EXPERIMENTAL DERMATOLOGY
- Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis
- (2015) Jamie L. Harden et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis
- (2015) Safia Hussain et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14 , but Not with Loss-of-Function Mutations in IL36RN in European Patients
- (2015) Rotraut Mössner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris
- (2015) Dorottya M. Berki et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis
- (2015) Wolf-Henning Boehncke et al. LANCET
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- AP1S3 Mutations Are Associated with Pustular Psoriasis and Impaired Toll-like Receptor 3 Trafficking
- (2014) Niovi Setta-Kaffetzi et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Immunology of Psoriasis
- (2014) Michelle A. Lowes et al. Annual Review of Immunology
- Partial clinical response to anakinra in severe palmoplantar pustular psoriasis
- (2014) M. Tauber et al. BRITISH JOURNAL OF DERMATOLOGY
- Mechanisms and Functions of Inflammasomes
- (2014) Mohamed Lamkanfi et al. CELL
- Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis
- (2014) Trine Bertelsen et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis
- (2014) Howard Sofen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CARD14 c.526G>C (p.Asp176His) Is a Significant Risk Factor for Generalized Pustular Psoriasis with Psoriasis Vulgaris in the Japanese Cohort
- (2014) Kazumitsu Sugiura et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
- (2014) Andrea Chiricozzi et al. PLoS One
- The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
- (2014) Roberto Lande et al. Nature Communications
- IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants
- (2014) Andrea Saggini et al. Journal of Immunology Research
- Successful Treatment of Generalized Pustular Psoriasis With the Interleukin-1-Receptor Antagonist Anakinra: Lack of Correlation With IL1RN Mutations
- (2013) Manuelle Viguier ANNALS OF INTERNAL MEDICINE
- A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
- (2013) W.C. Ports et al. BRITISH JOURNAL OF DERMATOLOGY
- Is it relevant to use an interleukin-1-inhibiting strategy for the treatment of patients with deficiency of interleukin-36 receptor antagonist?
- (2013) M. Tauber et al. BRITISH JOURNAL OF DERMATOLOGY
- Successful therapy with anakinra in a patient with generalized pustular psoriasis carryingIL36RNmutations
- (2013) U. Hüffmeier et al. BRITISH JOURNAL OF DERMATOLOGY
- Loss of IL36RN Function Does Not Confer Susceptibility to Psoriasis Vulgaris
- (2013) Dorottya M. Berki et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment-Related Restoration of Langerhans Cell Migration in Psoriasis
- (2013) Frances L. Shaw et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Transforming Growth Factor- Signaling in T Cells Promotes Stabilization of Atherosclerotic Plaques Through an Interleukin-17-Dependent Pathway
- (2013) A. Gistera et al. Science Translational Medicine
- PSORS2 Is Due to Mutations in CARD14
- (2012) Catherine T. Jordan et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Acitretin- and Tumor Necrosis Factor Inhibitor –Resistant Acrodermatitis Continua of Hallopeau Responsive to the Interleukin 1 Receptor Antagonist Anakinra
- (2012) Virginie Lutz ARCHIVES OF DERMATOLOGY
- Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
- (2012) Peter Schafer BIOCHEMICAL PHARMACOLOGY
- Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis
- (2012) C. Morales-Múnera et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-36 in psoriasis
- (2012) JE Towne et al. CURRENT OPINION IN PHARMACOLOGY
- Discontinued drugs 2011: pulmonary, allergy, gastrointestinal and arthritis
- (2012) Sabina A Antoniu EXPERT OPINION ON INVESTIGATIONAL DRUGS
- IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
- (2012) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature
- (2012) SATVEER K. Mahil et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- A Single Intradermal Injection of IFN-γ Induces an Inflammatory State in Both Non-Lesional Psoriatic and Healthy Skin
- (2012) Leanne M. Johnson-Huang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genetics of Psoriasis: Evidence for Epistatic Interaction between Skin Barrier Abnormalities and Immune Deviation
- (2012) Judith G.M. Bergboer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial
- (2012) Kim A. Papp et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis
- (2012) Naresh Punwani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of pustular psoriasis: From the Medical Board of the National Psoriasis Foundation
- (2012) Amanda Robinson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial
- (2012) Kim Papp et al. LANCET
- Interleukin-17 contributes to cardiovascular diseases
- (2012) Hua-Sheng Ding et al. MOLECULAR BIOLOGY REPORTS
- TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
- (2012) Adam P. Gregory et al. NATURE
- Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
- (2012) Lam C Tsoi et al. NATURE GENETICS
- The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90
- (2012) Chenhui Wang et al. NATURE IMMUNOLOGY
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases
- (2012) Jason S. Knight et al. Frontiers in Immunology
- Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis
- (2011) Alexandros Onoufriadis et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Pharmacological and therapeutic effects of A3 adenosine receptor agonists
- (2011) Pnina Fishman et al. DRUG DISCOVERY TODAY
- Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis
- (2011) Marie-José Bijlmakers et al. HUMAN MOLECULAR GENETICS
- Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
- (2011) Greta Guarda et al. IMMUNITY
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- Alternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-κB activation and endoplasmic reticulum stress-induced cell death
- (2011) Ivan Scudiero et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Psoriasis and Other Complex Trait Dermatoses: From Loci to Functional Pathways
- (2011) Francesca Capon et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial
- (2011) M. David et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
- (2011) Slaheddine Marrakchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12
- (2011) Stefano M. Santini et al. PLoS One
- The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
- (2011) Paola Di Meglio et al. PLoS One
- Expression of antimicrobial peptides and proteins in etanercept-treated psoriasis patients
- (2011) T. Gambichler et al. REGULATORY PEPTIDES
- Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy
- (2010) S. Coimbra et al. BRITISH JOURNAL OF DERMATOLOGY
- Ustekinumab: effective in a patient with severe recalcitrant generalized pustular psoriasis
- (2010) E. Daudén et al. BRITISH JOURNAL OF DERMATOLOGY
- Tuberculosis and anti-TNF treatment: experience of a central London hospital
- (2010) Satveer Mankia et al. CLINICAL RHEUMATOLOGY
- Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?
- (2010) P. Lakatos et al. CURRENT DRUG TARGETS
- Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis
- (2010) Lisa C. Zaba et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons
- (2010) Josh Gregorio et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effective Narrow-Band UVB Radiation Therapy Suppresses the IL-23/IL-17 Axis in Normalized Psoriasis Plaques
- (2010) Leanne M. Johnson-Huang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Langerhans Cell Mobilization Distinguishes between Early-Onset and Late-Onset Psoriasis
- (2010) Frances L. Shaw et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Subpopulation of CD163-Positive Macrophages Is Classically Activated in Psoriasis
- (2010) Judilyn Fuentes-Duculan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2
- (2010) Eva Ellinghaus et al. NATURE GENETICS
- A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
- (2010) Amy Strange et al. NATURE GENETICS
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
- (2010) Christopher E.M. Griffiths et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the Psoriasis Transcriptome across Different Studies by Gene Set Enrichment Analysis (GSEA)
- (2010) Mayte Suárez-Fariñas et al. PLoS One
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis
- (2010) Mona Gandhi et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Assessing Long-Term Drug Safety: Lessons (Re) Learned from Raptiva
- (2010) Nicole M. Seminara et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
- (2009) X Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
- (2009) Yeonseok Chung et al. IMMUNITY
- Cytokine-Producing Dendritic Cells in the Pathogenesis of Inflammatory Skin Diseases
- (2009) Leanne M. Johnson-Huang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
- (2009) Dipyaman Ganguly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
- (2009) Shinji Kagami et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis
- (2009) Rafael de Cid et al. NATURE GENETICS
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
- (2009) Rajan P Nair et al. NATURE GENETICS
- Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells
- (2009) Sara Trifari et al. NATURE IMMUNOLOGY
- Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
- (2009) Thomas Duhen et al. NATURE IMMUNOLOGY
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin
- (2009) Patrick A. M. Jansen et al. PLoS One
- Antimicrobial peptides and self-DNA in autoimmune skin inflammation
- (2008) Michel Gilliet et al. CURRENT OPINION IN IMMUNOLOGY
- Identification of ZNF313 / RNF114 as a novel psoriasis susceptibility gene
- (2008) Francesca Capon et al. HUMAN MOLECULAR GENETICS
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
- (2008) Michelle A. Lowes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Resident and “Inflammatory” Dendritic Cells in Human Skin
- (2008) Lisa C. Zaba et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Induction and effector functions of TH17 cells
- (2008) Estelle Bettelli et al. NATURE
- IFN-α Enhances Poly-IC Responses in Human Keratinocytes by Inducing Expression of Cytosolic Innate RNA Receptors: Relevance for Psoriasis
- (2007) Errol P. Prens et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More